Proteostasis Therapeutics, Inc. (NASDAQ: PTI) announced today that it has priced an underwritten public offering of 11,000,000 shares of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE